# PALBOCICLIB
> **ANDA213152** · Abbreviated New Drug Application (Generic) · Sponsor: AIZANT DRUG RESEARCH SOLUTIONS PVT LTD · Approved 2022-03-04
## Drug
- **FDA Application Number:** ANDA213152
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PALBOCICLIB
- **Generic name:** Palbociclib
- **Active ingredients:** PALBOCICLIB
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** AIZANT DRUG RESEARCH SOLUTIONS PVT LTD
- **First approval:** 2022-03-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213152)
---
*AI Analytics · CC0 1.0*